Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Colesevelam for Lenalidomide Associated Diarrhea in Patients with Multiple Myeloma.

Autor: Hultcrantz M; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Hassoun H; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Korde N; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Maclachlan K; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Mailankody S; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Patel D; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Shah U; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Tan CR; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Chung DJ; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Lahoud O; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Landau H; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Scordo M; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Shah GL; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Giralt S; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Pianko MJ; Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA., Burge M; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Barnett K; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Salcedo M; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Caple J; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Tran L; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Blaslov J; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Shekarkhand T; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Hamid S; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Nemikovski D; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Derkach A; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Arisa O; Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD., Peer CJ; Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD., Figg WD; Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD., Usmani SZ; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Landgren O; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Lesokhin AM; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.

Publikováno v: Research square [Res Sq] 2024 Jun 05. Date of Electronic Publication: 2024 Jun 05.